Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > $TLTFF Darling... CAN WE JUST TALK??.. CAN WE JUST TALK??
View:
Post by floatinketucky on Feb 22, 2022 7:35am

$TLTFF Darling... CAN WE JUST TALK??.. CAN WE JUST TALK??

THINK ABOUT WHERE XRAY IS GOING??

Theralase® Granted United States Patent to Destroy Cancer Cells with X-Ray Activated Photo Dynamic Compounds March 4, 2019

I just found it interesting back when they released the above release that they included bladder cancer.

Back in the day they were publishing info on solid tumor work.

New lab and they are getting things done for sure!

Did ya'll see that fund mangers face when they were asking Shawn if lil ol therylase could get to standard of care for NMIBC...hahhahhhha   golden moment...hhshshshshshs
Shawn stonewalled them alll....hahahhahahaha
Cool a$$ a freakin ice cube baby....   hahahahha
Shawn knows....


Hey... check into patient 4 from study one.. yeah dig into that about the rules the FDA had to change/clarify/set up for this study.  Yeah Theralse almost hit 100 percent there...

Bullish baby bullish... Let's go!


TLTFF the science is strong in this one!

Look to the cost expense/number  of treatments for alternatives. BCG is in short supplly. A treatment like that using scare resources will always be expensive. 
.
Alternative treatments are very cost prohibative
and will have a very  very very difficult time competing with Theralase.

JMO  Time for a coffee.

While others are giving their numbers a nice massage.
Theralase dialed  things back on this freakin beast for cation then after they let the kids drive the care with dad well they are ready to drive it for themselfs.....  YES Baby YES.....

Full doses and full throttle!!

TLTFF for NMIBC NONRESPONSE!!

Comment by Legit62 on Feb 22, 2022 8:05am
Oh Boooooooy!!!!!! I can hear the engine revvvvvvvving!!! can't wait till foot off the clutch, soon, next monday IMO
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250